-
Patient-derived xenograft models of head and neck cancers
Dac
EGAC50000000502
-
Brain Cancer Center Committee
Dac
EGAC50000000456
-
The Cancer Dependency Map (DepMap)
Study
phs003444
-
Genomic Landscape of Colorectal Cancer in a Multi-Ancestry Cohort
Study
phs003464
-
International Cancer Proteogenome Consortium (ICPC): Proteogenomics of Oral Squamous Cell Carcinoma in Taiwan
Study
phs002580
-
Childhood Cancer Data Initiative (CCDI): CCDI Pediatric In Vivo Testing Program - Leukemia
Study
phs003164
-
Count Me In (CMI): The Metastatic Breast Cancer (MBC) Project (CMI-MBCproject)
Study
phs001709
-
Exome Recapture and Sequencing of Prospectively Characterized Clinical Specimens From Cancer Patients
Study
phs001783
-
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
Study
phs003845
-
Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program - Neuroblastoma
Study
phs003163
-
Women's Health Initiative Clinical Trial and Observational Study - Imaging
Study
phs003824
-
Single-Cell ATAC and RNA Sequencing of Human Breast Cancer Reveals Salient Cancer-Specific Enhancers
Study
phs003253
-
Transcriptome-Wide Association Study (TWAS) to Identify Susceptibility Genes for Colorectal Cancer
Study
phs002813
-
TIGER-LC High-Throughput Sequencing
Study
phs001199
-
CALGB 40601: Randomized Phase III Trial of Paclitaxel Combined With Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer
Study
phs001570
-
A Clone's Genomic Stability as a Biomarker of Its DNA-Damage Resilience
Study
phs003762
-
Multi-Modal Single-Cell, Spatial, and Genomic Analyses of Human Non-Small Cell Lung Cancer Brain Metastases
Study
phs003865
-
Metabolic Biomarkers in Thoracic Cancers
Study
phs003880
-
National Cancer Institute Multi-Ancestry Genome-Wide Association Study of Kidney Cancer (NCI-3)
Study
phs003505
-
A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in High-Risk Renal Cell Carcinoma
Study
phs003710
-
NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Study
phs003833
-
HPV-associated Cancer Consortium Data Access Committee
Dac
EGAC50000000088
-
Spatial Transcriptomics of Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Study
phs003862
-
MP2PRT: Genomic and Molecular Characterization of Biomarkers Associated with Tumor Angiogenesis, DNA Repair, and Immunologic Tolerance using Samples from the NRG Oncology Phase 3 Randomized Trial, GOG-0240 (NCT00803062)
Study
phs002293
-
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification
Study
phs003648
-
Germline Genetics of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Study
phs002962
-
California Teachers Study (CTS): Whole Genome Sequences From Under-Represented Populations
Study
phs002918
-
Cancer-Restricted Cryptic Antigens Are Targets for T Cell Recognition
Study
phs003887
-
Understanding Determinants of Racial Disparities in Lung Cancer Incidence
Study
phs003789
-
Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the Neoadjuvant Setting
Study
phs003275
-
Genetic Studies of Homologous Recombination Deficiency in Hispanic Gastric Cancer
Study
phs003251
-
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-Based Cohorts (LEANORA)
Study
phs003770
-
Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer
Study
phs003438
-
Immune-Related Adverse Events after Immune Checkpoint Blockade-Based Therapy are Associated with Improved Survival in Advanced Sarcoma
Study
phs003284
-
Cancer Moonshot Biobank
Study
phs002192
-
DAC for "Establishment and characterization of circulating tumor cells-derived organoids from metastatic breast cancer patients."
Dac
EGAC50000000371
-
Yale Policy for head and neck cancer and HPV clinical trials
Dac
EGAC50000000403
-
CANCAP03 Data Access Committee
Dac
EGAC50000000508
-
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA Sequencing
Study
phs003801
-
DAC for "Copy number variations and fragmentation features in cell-free DNA predict response in advanced non-small cell lung cancer patients under anti-PD-(L)1 therapy"
Dac
EGAC50000000308
-
Proteogenomic Analysis of CALGB40601 (ALLIANCE) a Neoadjuvant Phase III HER2-Positive Breast Cancer Trial
Study
phs003576
-
DNA Methylation in Prostate Tumor and Paired Benign Tissue for African and European Ancestry Men
Study
phs003516
-
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
Study
phs003922
-
Timing and trajectory of BCR-ABL1 driven chronic myeloid leukaemia
Dataset
EGAD00001015473
-
The data access committee for Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
Dac
EGAC50000000588
-
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Study
phs003294
-
Durvalumab Plus Tremelimumab Alone or in Combination with Low-Dose or Hypofractionated Radiotherapy in Metastatic Non-Small-Cell Lung Cancer Refractory to Previous PD(L)-1 Therapy: an Open-Label, Multicentre, Randomised, Phase 2 Trial
Study
phs003295
-
Sequencing of 3D Organoids Derived From Colorectal Cancer Patients
Study
phs003965
-
Childhood Cancer Data Initiative (CCDI): Comprehensive Genomic Sequencing of Pediatric Cancer Cases (CMRI/KUCC)
Study
phs002529
-
DirectHRD Enables Sensitive Scar-Based Classification of Homologous Recombination Deficiency (HRD)
Study
phs003760